Protein Information

ID 428
Name factor is
Synonyms C3 inactivator; C3B/C4B inactivator; C3b inactivator; C3b INA; CFI; CFI protein; Complement component 3 inactivator; Complement component I…

Compound Information

ID 1242
Name cyanamide
CAS cyanamide

Reference

PubMed Abstract RScore(About this table)
1331403 Fukuto JM, Chiang K, Hszieh R, Wong P, Chaudhuri G: The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1992 Nov;263(2):546-51.
Chemical oxidation of N-hydroxy-L-arginine (NOHA) and other N-hydroxyguanidines has been previously shown to generate either nitric oxide (NO) or nitroxyl (HNO), depending on the oxidative conditions. Because N-hydroxy-L-arginine has been demonstrated to be a biosynthetic intermediate in the oxidative conversion of arginine to endothelium-derived relaxing factor, the possible formation of HNO through a biological process was considered. This study, therefore, explores the biological activity of HNO as a possible effector molecule, and the results indicate that HNO is capable of eliciting vasorelaxation in both rabbit aorta and bovine intrapulmonary artery by a guanylate cyclase-dependent pathway. The pharmacological properties of HNO were very similar to those of endothelium-derived relaxing factor, and the possible relationship between HNO and endothelium-derived relaxing factor is discussed.
1(0,0,0,1)